Al B Reid is a transformational and visionary business leader with Fortune 50 experience in stra-tegic, financial management, and operational matters. As a professional, Mr. Reid has worked to create long-term value for companies, shareholders, and communities via effective execution of cor-porate initiatives. During his career, Mr. Reid has worked globally and have led or supported over 30 transactions valued at $25 billion. Mr. Reid understands the role of a Board member drawing upon their business perspective / know-how to grow and scale-up a business as well as guiding manage-ment by asking the right questions.
Mr. Reid served as a Vice President of the Corporate Development Organization of Abbott Labo-ratories for over 20 years as strategic partner to Abbott’s worldwide business units and corporate centers. Through his leadership and strategic thinking, Mr. Reid was instrumental in evaluating and executing several key growth initiatives through inorganic activities. The focused health care-related investments including acquisitions (Humira), corporate spinoffs (AbbVie, Hospira, and Edwards), divestitures and strategic partnerships (China, Africa) which were defined by their scale and scope. Mr. Reid has also led Abbott’s Corporate Strategy and Business Analytics group that supported business enterprise clients with the implementation of all aspects of their business strategy, opera-tions, and product portfolio needs. Mr. Reid has a track record of pushing organizational out the box thinking and providing top-tier strategy consultancy.
Before joining Abbott, Mr. Reid was the Vice President of Strategy and Development at Baxter Health-care for over 9 years with global responsibilities for strategy & business development and financial growth. Previously Mr. Reid also held positions of increasing responsibilities at Dun & Bradstreet, Paramount Communications and the Federal Reserve Bank in M&A, finance, treasury, and manage-ment consulting.